Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation CarriersEISEN, Andrea; LUBINSKI, Jan; MANOUKIAN, Siranoush et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 19, pp 1361-1367, issn 0027-8874, 7 p.Article

Is Mammography Adequate for Screening Women with Inherited BRCA Mutations and Low Breast Density?BIGENWALD, Rachel Z; WARNER, Ellen; YAFFE, Martin J et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 3, pp 706-711, issn 1055-9965, 6 p.Article

Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSINING CHEN; IVERSEN, Edwin S; CORIO, Camille et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 863-871, issn 0732-183X, 9 p.Article

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen : Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 TrialMAMOUNAS, Eleftherios P; JEONG, Jong-Hyeon; PAJON, Eduardo R et al.Journal of clinical oncology. 2008, Vol 26, Num 12, pp 1965-1971, issn 0732-183X, 7 p.Article

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancerPIERCE, Lori J; LEVIN, Albert M; NAROD, Steven A et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2437-2443, issn 0732-183X, 7 p.Article

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionCHLEBOWSKI, Rowan T; COL, Nananda; WINER, Eric P et al.Journal of clinical oncology. 2002, Vol 20, Num 15, pp 3328-3343, issn 0732-183XArticle

Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKOTSOPOULOS, Joanne; LUBINSKI, Jan; SENTER, Leigha et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 7, pp 1089-1096, issn 1055-9965, 8 p.Article

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers : The PROSE study groupREBBECK, Timothy R; FRIEBEL, Tara; EELES, Rosalind et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7804-7810, issn 0732-183X, 7 p.Article

Effect of radiotherapy after breast-conserving Treatment in women with breast cancer and germline BRCA1/2 mutationsPIERCE, Lori J; STRAWDERMAN, Myla; BERG, Christine et al.Journal of clinical oncology. 2000, Vol 18, Num 19, pp 3360-3369, issn 0732-183XArticle

The Impact of Having a Sister Diagnosed With Breast Cancer on Cancer-Related Distress and Breast Cancer Risk PerceptionMETCALFE, Kelly A; QUAN, May-Lynn; EISEN, Andrea et al.Cancer. 2013, Vol 119, Num 9, pp 1722-1728, issn 0008-543X, 7 p.Article

Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 MutationsMETCALFE, Kelly; LUBINSKI, Jan; AINSWORTH, Peter et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 24, pp 1874-1878, issn 0027-8874, 5 p.Article

Systematic Review : Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast CancerWARNER, Ellen; MESSERSMITH, Hans; CAUSER, Petrina et al.Annals of internal medicine. 2008, Vol 148, Num 9, pp 671-679, issn 0003-4819, 9 p.Article

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers : an updateGRONWALD, Jacek; TUNG, Nadine; SAAL, Howard et al.International journal of cancer. 2006, Vol 118, Num 9, pp 2281-2284, issn 0020-7136, 4 p.Article

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening ProgramCHIARELLI, Anna M; PRUMMEL, Maegan V; RABENECK, Linda et al.Journal of clinical oncology. 2014, Vol 32, Num 21, pp 2224-2230, issn 0732-183X, 7 p.Article

The symptom appraisal of breast cancer in the context of an intimate relationshipFERGUS, Karen; FITZGERALD, Barbara; GRANEK, Leeat et al.Journal of health psychology. 2011, Vol 16, Num 4, pp 653-666, issn 1359-1053, 14 p.Article

Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriersNKONDJOCK, André; GHADIRIAN, Parviz; FOULKES, William et al.International journal of cancer. 2006, Vol 118, Num 1, pp 103-107, issn 0020-7136, 5 p.Article

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers : An international case-control studyEISEN, Andrea; LUBINSKI, Jan; FOULKES, William D et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7491-7496, issn 0732-183X, 6 p.Article

The risk of breast cancer in women with a BRCA1 mutation from North America and PolandLUBINSKI, Jan; HUZARSKI, Tomasz; NEUHAUSEN, Susan L et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 229-234, issn 0020-7136, 6 p.Article

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163ELLARD, Susan L; CLEMONS, Mark; SAUERBREI, Eric et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4536-4541, issn 0732-183X, 6 p.Article

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersKOTSOPOULOS, Joanne; LUBINSKI, Jan; DOMCHEK, Susan et al.Breast cancer research and treatment. 2007, Vol 105, Num 2, pp 221-228, issn 0167-6806, 8 p.Article

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersMETCALFE, Kelly; LYNCH, Henry T; PING SUN et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2328-2335, issn 0732-183X, 8 p.Article

Application of breast cancer risk prediction models in clinical practiceDOMCHEK, Susan M; EISEN, Andrea; CALZONE, Kathleen et al.Journal of clinical oncology. 2003, Vol 21, Num 4, pp 593-601, issn 0732-183X, 9 p.Article